Gossamer Bio Inc [NASDAQ: GOSS] price plunged by -3.85 percent to reach at $1539998.7.
A sum of 26035296 shares traded at recent session while its average daily volume was at 1.54M shares. Gossamer Bio Inc shares reached a high of $1.3298 and dropped to a low of $1.2 until finishing in the latest session at $1540000.0.
The one-year GOSS stock forecast points to a potential downside of -20236430.88. The average equity rating for GOSS stock is currently 1.44, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Gossamer Bio Inc [GOSS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GOSS shares is $7.61 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GOSS stock is a recommendation set at 1.44. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for Gossamer Bio Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 25, 2024. While these analysts kept the previous recommendation, Wedbush raised their target price to Outperform. The new note on the price target was released on April 05, 2024, representing the official price target for Gossamer Bio Inc stock. Previously, the target price had yet another drop from $8 to $1.25, while UBS kept a Neutral rating on GOSS stock.
GOSS Stock Performance Analysis:
Gossamer Bio Inc [GOSS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -13.19. With this latest performance, GOSS shares gained by 7.76% in over the last four-week period, additionally plugging by 45.69% over the last 6 months – not to mention a rise of 38.18% in the past year of trading.
Insight into Gossamer Bio Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Gossamer Bio Inc [GOSS] shares currently have an operating margin of -43.96% and a Gross Margin at 97.20%. Gossamer Bio Inc’s Net Margin is presently recorded at -41.13%.
Return on Equity for this stock declined to -18.98%, with Return on Assets sitting at -18.98%.
GOSS Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GOSS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Gossamer Bio Inc go to 15.97%.
Gossamer Bio Inc [GOSS] Institutonal Ownership Details
There are presently around $75.98%, or 78.74% of GOSS stock, in the hands of institutional investors. The top three institutional holders of GOSS stocks are: NEA MANAGEMENT COMPANY, LLC with ownership of 18.09 million shares, which is approximately 7.9979%. ARTAL GROUP S.A., holding 13.31 million shares of the stock with an approximate value of $$11.99 million in GOSS stocks shares; and ARTAL GROUP S.A., currently with $$10.59 million in GOSS stock with ownership which is approximately 5.1986%.
